High Granular Tick Data API: US Stocks Learn more

Try our APIs with free plan!

Evommune, Inc. Financial Data Overview

Price chart is built with Anychart

Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Its products include EVO756 for the treatment of CSU and AD; and EVO301 for the treatment of AD and UC. The company was incorporated in 2020 and is headquartered in Palo Alto, California.

Prev. Close 6.7081
Open 6.4577
High 6.7868
Low 6.2217
52 wk Range 4.94-33.2
Market Cap 241 M
Shares Outstanding 36 292 K
Revenue 10 000 K
EPS -0.89

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


ETFs with Evommune, Inc. (top by weight)

Ticker
100-day Price Change
Weight
BBC.US Virtus LifeSci Biotech Clinical Trials ETF
-5.72 (-11.73%)
0.26
BUSM.US EA Bridgeway Ultra-Small Company Market ETF
-1.22 (-7.51%)
0.23
SBIO.US ALPS Medical Breakthroughs ETF
-7.58 (-11.97%)
0.16
ACSG.US American Century Small Cap Growth Insights ETF
-2.79 (-5.86%)
0.14
IWC.US iShares Micro-Cap ETF
-15.22 (-8.13%)
0.03
FESM.US Fidelity Enhanced Small Cap ETF
-2.19 (-4.72%)
0.02
VTWG.US Vanguard Russell 2000 Growth Index Fund ETF Shares
-19.28 (-7.13%)
0.01
VRTGX.US Vanguard Russell 2000 Growth Index Fund Institutional Shares
-36.96 (-7.17%)
0.01
IWO.US iShares Russell 2000 Growth ETF
-26.39 (-7.13%)
0.01
ISCG.US iShares Morningstar Small-Cap Growth ETF
-2.94 (-4.71%)
0.00

* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.


Why to choose EODHD?

Prices start at €19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only €19.99

TRY NOW

Get Evommune, Inc. data using free add-ons & libraries


Get Evommune, Inc. Fundamental Data

Evommune, Inc. Fundamental data includes:

  • Net Revenue: 10 000 K
  • EBITDA: -100 356 000
  • Earnings Per Share: -3
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

€ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Evommune, Inc. Earnings data

Corporate Events Calendar & News package for

€ 19.99 /mo.

What’s included:

  • Latest Release: 2026-08-06
  • EPS/Forecast: -0.68
GET THE PACKAGE

Get Evommune, Inc. End-of-day data

EOD Historical Data package for

€ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Evommune, Inc. News

Get Evommune, Inc. fresh news feed via Financial News API

Corporate Events Calendar & News package for

€19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only €19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
€99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE

Send the request

Leave your email and our team will contact you ASAP.